DocGo Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

DocGo şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

2.8%

Geri Alım Getirisi

Toplam Hissedar Getirisi	2.8%
Gelecekteki Temettü Verimi	0%
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Recent updates

New Forecasts: Here's What Analysts Think The Future Holds For DocGo Inc. (NASDAQ:DCGO)

Nov 08

Is Now The Time To Look At Buying DocGo Inc. (NASDAQ:DCGO)?

Jun 07

DocGo Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

May 10

DocGo Inc.'s (NASDAQ:DCGO) Price In Tune With Earnings

Apr 07

DocGo's UK subsidiary Ambulnz Community Partners secures three new contracts

Sep 20

DocGo: 'Last Mile' Care More Palatable To The Public Than Telemedicine

Aug 31

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: DCGO şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: DCGO şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

DocGo Piyasaya Karşı Temettü Getirisi

DCGO temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (DCGO)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.3%
Sektör Ortalaması (Healthcare)	1.7%
Analist tahmini (DCGO) (3 yıla kadar)	0%

Önemli Temettü: DCGO şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, DCGO şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: DCGO şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: DCGO herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

DocGo Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

DocGo Inc. (NasdaqCM:DCGO) announces an Equity Buyback for $36 million worth of its shares.

DocGo Inc. (NasdaqCM:DCGO) announces an Equity Buyback for $40 million worth of its shares.

DocGo Inc. (NasdaqCM:DCGO) announces an Equity Buyback for $40 million worth of its shares.

Recent updates

Investor sentiment improves as stock rises 16%

Third quarter 2024 earnings: EPS exceeds analyst expectations

DocGo Inc. Provides Earnings Guidance for the Year 2024 and 2025

DocGo Inc. to Report Q3, 2024 Results on Nov 07, 2024

DocGo Inc. Announces Board Changes

DocGo Inc. Appoints Eiwe Lingefors as Chief Information Officer

New major risk - Revenue and earnings growth

New minor risk - Share price stability

Second quarter 2024 earnings: EPS misses analyst expectations

Investor sentiment deteriorates as stock falls 15%

DocGo Inc. (NASDAQ:DCGO) Doing What It Can To Lift Shares

DocGo Inc. to Report Q2, 2024 Results on Aug 07, 2024

At US$3.40, Is DocGo Inc. (NASDAQ:DCGO) Worth Looking At Closely?

Investor sentiment improves as stock rises 20%

Ambulnz by DocGo Launches Emergency Medical Services in Dover, Delaware

DocGo Inc. Establishes Medical Advisory Board

These 4 Measures Indicate That DocGo (NASDAQ:DCGO) Is Using Debt Safely

CEO & Director recently bought US$79k worth of stock

First quarter 2024 earnings: EPS exceeds analyst expectations

DocGo Inc. Provides Earnings Guidance for the Year 2024

DocGo Inc., Annual General Meeting, Jun 18, 2024

DocGo Inc. to Report Q1, 2024 Results on May 08, 2024

Investor sentiment deteriorates as stock falls 15%

DocGo: Upside Remains Attractive After Share Price Decline

DocGo Inc. Announces Board Changes

Full year 2023 earnings: EPS misses analyst expectations

DocGo Inc. Provides Earnings Guidance for the Full Year 2024

DocGo Inc. Announces Executive Appointments

DocGo Inc. to Report Q4, 2023 Results on Feb 28, 2024

Does DocGo (NASDAQ:DCGO) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 16%

DocGo: Good Performance, Trust Issues

DocGo Inc. (NasdaqCM:DCGO) announces an Equity Buyback for $36 million worth of its shares.

Why DocGo Inc. (NASDAQ:DCGO) Could Be Worth Watching

DocGo Inc. Provides Revenue Guidance for Fiscal Year 2023 and 2024

Investor sentiment deteriorates as stock falls 39%

Fewer Investors Than Expected Jumping On DocGo Inc. (NASDAQ:DCGO)

The Gross Law Firm Notifies Shareholders of DocGo Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 26, 2023

Investor sentiment deteriorates as stock falls 15%

Consensus revenue estimates increase by 13%

DocGo Inc. Raises Revenue Guidance for the Year 2023

New Forecasts: Here's What Analysts Think The Future Holds For DocGo Inc. (NASDAQ:DCGO)

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Pomerantz Law Firm Announces the Filing of a Class Action against DocGo Inc. and Certain Officers

Pomerantz Law Firm Announces the Filing of a Class Action against DocGo Inc. and Certain Officers

New minor risk - Share price stability

DocGo Inc. to Report Q3, 2023 Results on Nov 06, 2023

DocGo Inc. Appoints Lee Bienstock as CEO

DocGo Inc. Announces the Resignation of Lee Bienstock as President and Chief Operating Officer

Insider recently sold US$1.3m worth of stock

Consensus EPS estimates fall by 24%, revenue upgraded

Consensus EPS estimates fall by 29%, revenue upgraded

DocGo Inc. Raises Earnings Guidance for the Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

DocGo Inc. to Report Q2, 2023 Results on Aug 07, 2023

Is Now The Time To Look At Buying DocGo Inc. (NASDAQ:DCGO)?

Independent Director notifies of intention to sell stock

Independent Director recently sold US$1.1m worth of stock

Consensus EPS estimates fall by 22%

DocGo Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

DocGo Inc. Reiterates Earnings Guidance for the Year 2023

DocGo Inc.'s (NASDAQ:DCGO) Price In Tune With Earnings

Consensus EPS estimates fall by 23%, revenue upgraded

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improved over the past week

DocGo Inc. Announces Executive Changes

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

DocGo Appoints Veteran Technology Human Resources Executive Vina Leite, MS, to Its Board of Directors and Announces Key Leadership Promotions

DocGo Inc. Announces Executive Changes

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind